Search This Blog

Wednesday, September 11, 2019

Monopar Therapeutics sets IPO terms

Monopar Therapeutics (MNPR) has filed a preliminary prospectus for its IPO of 4,444,445 common shares at $8 – 10.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)